EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EQS - FR0012882389 - Common Stock
42.95 EUR
+0.05 (+0.12%)
Overall EQS gets a fundamental rating of 6 out of 10. We evaluated EQS against 11 industry peers in the Health Care Technology industry. While EQS has a great profitability rating, there are some minor concerns on its financial health. EQS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
In the past year EQS had a positive cash flow from operations.
Each year in the past 5 years EQS has been profitable.
In the past 5 years EQS always reported a positive cash flow from operatings.
1.2 Ratios
EQS has a better Return On Assets (8.84%) than 72.73% of its industry peers.
The Return On Equity of EQS (15.79%) is better than 90.91% of its industry peers.
EQS's Return On Invested Capital of 12.70% is amongst the best of the industry. EQS outperforms 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 9.17%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROIC | 12.7% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS has a Profit Margin of 16.15%. This is amongst the best in the industry. EQS outperforms 81.82% of its industry peers.
EQS's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 19.80%, EQS belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
EQS's Operating Margin has declined in the last couple of years.
EQS has a worse Gross Margin (68.81%) than 72.73% of its industry peers.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EQS has about the same amount of shares outstanding.
The number of shares outstanding for EQS has been increased compared to 5 years ago.
Compared to 1 year ago, EQS has an improved debt to assets ratio.
2.2 Solvency
EQS has an Altman-Z score of 3.98. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.98, EQS is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
EQS has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
EQS has a Debt to FCF ratio of 0.98. This is in the better half of the industry: EQS outperforms 63.64% of its industry peers.
EQS has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.09, EQS perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 3.98 |
ROIC/WACC1.64
WACC7.76%
2.3 Liquidity
EQS has a Current Ratio of 1.29. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.29, EQS is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a worse Quick ratio (1.20) than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The earnings per share for EQS have decreased strongly by -14.07% in the last year.
The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
Looking at the last year, EQS shows a small growth in Revenue. The Revenue has grown by 4.45% in the last year.
The Revenue has been growing slightly by 6.45% on average over the past years.
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
3.2 Future
The Earnings Per Share is expected to grow by 18.63% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.97 indicates a rather expensive valuation of EQS.
Based on the Price/Earnings ratio, EQS is valued a bit cheaper than 72.73% of the companies in the same industry.
EQS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.56 indicates a correct valuation of EQS.
81.82% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 36.56. EQS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.97 | ||
| Fwd PE | 13.56 |
4.2 Price Multiples
EQS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EQS is cheaper than 72.73% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.54 | ||
| EV/EBITDA | 8.92 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
A more expensive valuation may be justified as EQS's earnings are expected to grow with 18.63% in the coming years.
PEG (NY)1.38
PEG (5Y)3.51
EPS Next 2Y17.52%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 2.91%. Purely for dividend investing, there may be better candidates out there.
EQS's Dividend Yield is a higher than the industry average which is at 3.46.
Compared to an average S&P500 Dividend Yield of 2.32, EQS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
5.2 History
On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
51.75% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.75%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPA:EQS (11/28/2025, 7:00:00 PM)
42.95
+0.05 (+0.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap651.55M
Revenue(TTM)224.73M
Net Income(TTM)36.30M
Analysts83.33
Price Target52.36 (21.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.75%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.7%
PT rev (3m)3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.82%
EPS NY rev (3m)-4.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.97 | ||
| Fwd PE | 13.56 | ||
| P/S | 2.9 | ||
| P/FCF | 17.54 | ||
| P/OCF | 13.5 | ||
| P/B | 2.83 | ||
| P/tB | 8.16 | ||
| EV/EBITDA | 8.92 |
EPS(TTM)2.39
EY5.56%
EPS(NY)3.17
Fwd EY7.37%
FCF(TTM)2.45
FCFY5.7%
OCF(TTM)3.18
OCFY7.41%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.38
PEG (5Y)3.51
Graham Number28.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROCE | 15.59% | ||
| ROIC | 12.7% | ||
| ROICexc | 17.92% | ||
| ROICexgc | 69.44% | ||
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% | ||
| FCFM | 16.53% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-25.09%
ROICexgc growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 69.34% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 102.29% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.98 |
F-Score7
WACC7.76%
ROIC/WACC1.64
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-8.02%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-36.73%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-31.7%
OCF growth 3Y0.02%
OCF growth 5Y3.18%
EQUASENS / EQS.PA FAQ
What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.
What is the valuation status for EQS stock?
ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.
What is the profitability of EQS stock?
EQUASENS (EQS.PA) has a profitability rating of 7 / 10.
What is the expected EPS growth for EQUASENS (EQS.PA) stock?
The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 13% in the next year.
Can you provide the dividend sustainability for EQS stock?
The dividend rating of EQUASENS (EQS.PA) is 6 / 10 and the dividend payout ratio is 51.75%.